Search Results - "Goetz MP"

ASO Author Reflections: Low Estrogen Receptor (ER) Expression Breast Cancer Behaves More like ER Negative Disease and Influences Management.

Authors: Moldoveanu D Goetz MP Boughey JC

Source: Annals of surgical oncology [Ann Surg Oncol] 2023 Oct; Vol. 30 (11), pp. 6484-6485. Date of Electronic Publication: 2023 Jul 24.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

ASO Author Reflections: Sentinel Lymph Node Biopsy in Node-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Considerations and Emerging Evidence.

Authors: Dogan B; Department of Radiology, Breast Imaging Division, The University of Texas Southwestern Medical Center, Dallas, TX, USA. basak.dogan@utsouthwestern.edu.

Source: Annals of surgical oncology [Ann Surg Oncol] 2025 May; Vol. 32 (5), pp. 3331-3332. Date of Electronic Publication: 2025 Mar 07.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process

Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1.

Authors: Yu J Qin B Moyer AM et al.

Source: Cell research [Cell Res] 2020 Sep; Vol. 30 (9), pp. 823.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9425763 Publication Model: Print Cited Medium: Internet ISSN: 1748-7838 (Electronic) Linking ISSN: 10010602 NLM ISO Abbreviation: Cell Res Subsets: MEDLINE; PubMed not MEDLINE

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108.

Authors: Stearns V ONeill A Schneider BP et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 209 (3), pp. 595-602. Date of Electronic Publication: 2024 Oct 21.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.

Authors: Liu Y Carter JM Ma Y et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jun 03; Vol. 14 (6). Date of Electronic Publication: 2026 Jun 03.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase Cβ.

Authors: Cong ATQ Witter TL Bruinsma ES et al.

Source: Nature communications [Nat Commun] 2026 May 21. Date of Electronic Publication: 2026 May 21.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.

Authors: Wahner Hendrickson AE Flatten KS Weiskittel TM et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Oct 24; Vol. 11 (1), pp. 112. Date of Electronic Publication: 2025 Oct 24.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen.

Authors: Safgren SL Suman VJ Leon Ferre RA et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 May; Vol. 211 (1), pp. 261-270. Date of Electronic Publication: 2025 Feb 27.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.

Authors: Kahraman, Seda Hizal, Mutlu Demirel, Burcin Cakan et al.

Source: BMC Cancer. 12/30/2024, Vol. 24 Issue 1, p1-10. 10p.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Authors: Wang Y Drubay D Jonas SF et al.

Corporate Authors: Wang Y Drubay D Jonas SF et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 Apr 21. Date of Electronic Publication: 2026 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Next-Generation Therapeutic Targets in Triple-Negative Breast Cancer.

Authors: Saleem, Kalsoom Mohammed Amirova, Mahira Firudin Rahimov, Javanshir Ali et al.

Source: European Journal of Breast Health. 2026, Vol. 22 Issue 3, p240-247. 8p.

Effectiveness of pharmacogenomics-guided dosing in improving treatment outcomes.

Authors: Karthikeyan, L. V. Subamathi, A. Pragathi, P. et al.

Source: Indian Journal of Pharmacology. Jul/Aug2026, Vol. 58 Issue 4, p332-341. 10p.

Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India.

Authors: Mukherjee, Anindya Goyal, Pankaj Tripathi, Rupal et al.

Source: PLoS ONE. 5/15/2026, Vol. 21 Issue 5, p1-11. 11p.

CT-guided radiofrequency ablation and percutaneous cementoplasty in the treatment of bone metastases: a single-center experience.

Authors: Huang, Haozhe Chen, Hong Song, Ge et al.

Source: Med-X. 5/8/2026, Vol. 4 Issue 1, p1-10. 10p.

Immunotherapy innovations in triple-negative breast cancer: targeting checkpoints, combinations, and biomarkers.

Authors: Wang, Zi-Xin Chu, Ju-Hang Wang, Ya-Ru et al.

Source: Oncology Reviews. 2026, p1-12. 12p.

TMEM92 shields DDX3X from TTC3‐mediated degradation to confer chemoresistance in triple‐negative breast cancer.

Authors: Shen, Hao Jia, Xiaochao Li, Xu et al.

Source: Clinical & Translational Medicine. May2026, Vol. 16 Issue 5, p1-24. 24p.

Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance.

Authors: Schneider, Julia S. Khaled, Najib Ben Ye, Liangtao et al.

Source: Cellular Oncology (2211-3428). Oct2025, Vol. 48 Issue 5, p1363-1375. 13p.

Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.

Authors: Singareeka Raghavendra A Damodaran S Barcenas CH et al.

Source: CA: a cancer journal for clinicians [CA Cancer J Clin] 2026 Jan-Feb; Vol. 76 (1), pp. e70055.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0370647 Publication Model: Print Cited Medium: Internet ISSN: 1542-4863 (Electronic) Linking ISSN: 00079235 NLM ISO Abbreviation: CA Cancer J Clin Subsets: MEDLINE

Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study.

Authors: Tolaney SM Jhaveri K Helsten T et al.

Source: Frontiers in oncology [Front Oncol] 2025 Mar 12; Vol. 15, pp. 1555921. Date of Electronic Publication: 2025 Mar 12 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.

Authors: Hoppe R Winter S Lo WY et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Feb 19; Vol. 11 (1), pp. 18. Date of Electronic Publication: 2025 Feb 19.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE